Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapy.

Oncogene·2010
Same author

A 4D TROSY-based pulse scheme for correlating 1HNi,15Ni,13Calphai,13C'i-1 chemical shifts in high molecular weight, 15N,13C, 2H labeled proteins.

Journal of biomolecular NMR·2010
Same author

A Sensitive Pulse Scheme for Measuring the Backbone Dihedral Angle psi Based on Cross-correlation Between (13)C (alpha)- (1)Halpha Dipolar and Carbonyl Chemical Shift Anisotropy Relaxation Interactions.

Journal of biomolecular NMR·2010
Same author

Specific (15)N, NH correlations for residues in(15) N, (13)C and fractionally deuterated proteins that immediately follow methyl-containing amino acids.

Journal of biomolecular NMR·2010
Same author

Fabrication of Anti-human Cardiac Troponin I Immunogold Nanorods for Sensing Acute Myocardial Damage.

Nanoscale research letters·2010
Same author

The woodchuck: a model for therapeutic vaccination against hepadnaviral infection.

Pathologie-biologie·2010

Related Experiment Video

Updated: Aug 23, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K

HISMD: A Novel Immune Subtyping System for HNSCC.

D Yang1, Y Wu1, Z Wan2

  • 1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Journal of Dental Research
|November 5, 2022
PubMed
Summary

This study identifies three distinct immune subtypes in head and neck squamous cell carcinoma (HNSCC) using multi-omics data, revealing differences in prognosis and chemotherapy response. A novel deep learning system, HISMD, accurately predicts these subtypes from whole slide images.

Keywords:
deep learningimmune subtypemulti-omicspredictionsquamous cell carcinoma of head and neckwhole slide images

More Related Videos

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.2K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.8K

Related Experiment Videos

Last Updated: Aug 23, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
15:24

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

3.2K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.8K

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Immune heterogeneity in head and neck squamous cell carcinoma (HNSCC) influences disease progression and treatment response.
  • Existing immune subtyping methods often rely on single data types and lack comprehensive profiling.

Purpose of the Study:

  • To identify comprehensive immune subtypes in HNSCC using multi-omics data.
  • To develop and validate a novel deep learning-based prediction system for clinical application.

Main Methods:

  • Multi-omics clustering (gene expression, somatic mutations) of 499 HNSCC patients from TCGA.
  • Bioinformatic analysis to characterize immune features and biological differences.
  • Development and validation of a deep learning model (HISMD) using whole slide images.

Main Results:

  • Three immune subtypes were identified: adaptive immune activation (T cell-rich), innate immune activation (macrophage-rich), and immune desert.
  • Adaptive and innate immune activation subtypes showed better survival and similar chemotherapy response compared to the immune desert subtype, which may be chemoresistant.
  • The HISMD system demonstrated high accuracy, interpretability, and predictive stability in an independent cohort.

Conclusions:

  • This study reveals significant immune heterogeneity in HNSCC.
  • A novel, accurate, and interpretable immune subtyping prediction system (HISMD) was developed for HNSCC.
  • Further validation and utility studies are needed for clinical implementation.